- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting ARID1A Mutations in Cancer
Authors
Keywords
SWI/SNF, ARID1A, Chromatin remodeling
Journal
CANCER TREATMENT REVIEWS
Volume -, Issue -, Pages 102287
Publisher
Elsevier BV
Online
2021-09-06
DOI
10.1016/j.ctrv.2021.102287
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ARID1A mutation may define an immunologically active subgroup in patients with microsatellite-stable colorectal cancer
- (2021) Amir Mehrvarz Sarshekeh et al. CLINICAL CANCER RESEARCH
- ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer
- (2020) Guotai Xu et al. NATURE GENETICS
- ARID1A alterations function as a biomarker for longer progression-free survival after anti-PD-1/PD-L1 immunotherapy
- (2020) Ryosuke Okamura et al. Journal for ImmunoTherapy of Cancer
- Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy
- (2020) Jing Li et al. JOURNAL OF CLINICAL INVESTIGATION
- MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy
- (2020) Maria Grazia Rodriquenz et al. Journal of Clinical Medicine
- Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer
- (2019) Young-Bae Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer
- (2019) Saori Mishima et al. Journal for ImmunoTherapy of Cancer
- Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
- (2019) Jason K. Sicklick et al. NATURE MEDICINE
- Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
- (2019) Jordi Rodon et al. NATURE MEDICINE
- Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer
- (2019) Xuan Jiang et al. Cancer Management and Research
- Loss of ARID1A promotes proliferation, migration and invasion via the Akt signaling pathway in NPC
- (2019) Yang Yang et al. Cancer Management and Research
- Loss of ARID1A in tumor cells renders selective vulnerability to combined ionizing radiation and PARP inhibitor therapy
- (2019) Youngran Park et al. CLINICAL CANCER RESEARCH
- ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells
- (2019) Madhobi Sen et al. Clinical Epigenetics
- Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma
- (2019) Takafumi Kuroda et al. GYNECOLOGIC ONCOLOGY
- Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine
- (2019) Apostolia-Maria Tsimberidou et al. Journal of Hematology & Oncology
- ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies
- (2018) Joseph J. Caumanns et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
- (2018) Robert D. Morgan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2
- (2018) Qingyu Luo et al. CANCER LETTERS
- ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade
- (2018) Jianfeng Shen et al. NATURE MEDICINE
- ARID1A loss in cancer: Towards a mechanistic understanding
- (2018) Radhika Mathur PHARMACOLOGY & THERAPEUTICS
- Repurposing Pan-HDAC Inhibitors for ARID1A -Mutated Ovarian Cancer
- (2018) Takeshi Fukumoto et al. Cell Reports
- A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance
- (2018) Hsien-Ming Hu et al. Cell Reports
- Epstein–Barr Virus and Cancer
- (2018) Paul J. Farrell Annual Review of Pathology-Mechanisms of Disease
- Activation of the JAK/STAT3 and PI3K/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells
- (2018) Mulugeta M. Zegeye et al. Cell Communication and Signaling
- ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
- (2018) Stefan Garczyk et al. PLoS One
- Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities
- (2018) Sherri Z. Millis et al. CANCER
- Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
- (2017) Elizabeth M Swisher et al. LANCET ONCOLOGY
- ARID1A-mutated ovarian cancers depend on HDAC6 activity
- (2017) Benjamin G. Bitler et al. NATURE CELL BIOLOGY
- Somatic Host Cell Alterations in HPV Carcinogenesis
- (2017) Tamara Litwin et al. Viruses-Basel
- High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
- (2017) Christophe Massard et al. Cancer Discovery
- ATM Mutations in Cancer: Therapeutic Implications
- (2016) M. Choi et al. MOLECULAR CANCER THERAPEUTICS
- ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A
- (2016) Chris T. Williamson et al. Nature Communications
- Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors
- (2016) Sherri Z. Millis et al. JAMA Oncology
- Targeting tumor suppressor genes for cancer therapy
- (2015) Yunhua Liu et al. BIOESSAYS
- Potential therapeutic targets inARID1A-mutated cancers
- (2015) Benjamin G Bitler et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
- (2015) Benjamin G Bitler et al. NATURE MEDICINE
- Coexistent ARID1A–PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling
- (2015) Ronald L. Chandler et al. Nature Communications
- ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
- (2015) J. Shen et al. Cancer Discovery
- Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles
- (2015) Khine Myint et al. PLoS One
- Vulnerabilities of Mutant SWI/SNF Complexes in Cancer
- (2014) Katherine C. Helming et al. CANCER CELL
- SWI/SNF Factors Required for Cellular Resistance to DNA Damage Include ARID1A and ARID1B and Show Interdependent Protein Stability
- (2014) R. Watanabe et al. CANCER RESEARCH
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas
- (2013) Eleftherios Samartzis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
- (2013) Cigall Kadoch et al. NATURE GENETICS
- The ATM protein kinase: regulating the cellular response to genotoxic stress and more
- (2013) Yosef Shiloh et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Spectrum of SWI/SNF Mutations, Ubiquitous in Human Cancers
- (2013) A. Hunter Shain et al. PLoS One
- Haploinsufficiency of ARID1B , a Member of the SWI/SNF-A Chromatin-Remodeling Complex, Is a Frequent Cause of Intellectual Disability
- (2012) Juliane Hoyer et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative
- (2012) A.-M. Tsimberidou et al. CLINICAL CANCER RESEARCH
- SWI/SNF complex in disorder
- (2012) Gijs W.E. Santen et al. Epigenetics
- Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer
- (2012) H. Liang et al. GENOME RESEARCH
- Mutations in SWI/SNF chromatin remodeling complex gene ARID1B cause Coffin-Siris syndrome
- (2012) Gijs W E Santen et al. NATURE GENETICS
- Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome
- (2012) Jeroen K J Van Houdt et al. NATURE GENETICS
- The genetic landscape of mutations in Burkitt lymphoma
- (2012) Cassandra Love et al. NATURE GENETICS
- Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome
- (2012) Yoshinori Tsurusaki et al. NATURE GENETICS
- ARID1A Mutations in Cancer: Another Epigenetic Tumor Suppressor?
- (2012) Jennifer N. Wu et al. Cancer Discovery
- ARID1A, a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers
- (2011) B. Guan et al. CANCER RESEARCH
- Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B
- (2011) C Halgren et al. CLINICAL GENETICS
- Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma
- (2011) Atsuko Katagiri et al. MODERN PATHOLOGY
- Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations
- (2011) Sohei Yamamoto et al. MODERN PATHOLOGY
- Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
- (2011) Kai Wang et al. NATURE GENETICS
- A Balanced Translocation t(6;14)(q25.3;q13.2) Leading to Reciprocal Fusion Transcripts in a Patient with Intellectual Disability and Agenesis of Corpus Callosum
- (2010) L. Backx et al. CYTOGENETIC AND GENOME RESEARCH
- Structure and function of SWI/SNF chromatin remodeling complexes and mechanistic implications for transcription
- (2010) Liling Tang et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
- (2009) Kuan-Ting Kuo et al. AMERICAN JOURNAL OF PATHOLOGY
- Hijacking the Chromatin Remodeling Machinery: Impact of SWI/SNF Perturbations in Cancer
- (2009) B. Weissman et al. CANCER RESEARCH
- Understanding the Words of Chromatin Regulation
- (2009) Jiang I. Wu et al. CELL
- Meta-analysis Shows That Prevalence of Epstein–Barr Virus-Positive Gastric Cancer Differs Based on Sex and Anatomic Location
- (2009) Gwen Murphy et al. GASTROENTEROLOGY
- Variations in the composition of mammalian SWI/SNF chromatin remodelling complexes
- (2009) Jessica Ryme et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now